Evidence map›Paper›PMID 18470304›Full record

ArticleEnvironmental health perspectives2008

The polybrominated diphenyl ether mixture DE-71 is mildly estrogenic.

Minerva Mercado-Feliciano, Robert M Bigsby

Open access · diamondAbstract read
In one paragraph

Article in Environmental health perspectives, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 83 citations in OpenAlex.

  1. Breast cancer and persistent organic pollutants (excluding DDT): a systematic literature review.Environmental science and pollution research international · 2016
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Exposure to brominated flame retardantsFrontiers in endocrinology · 2024
    Article
  7. Toxic Effects and Mechanisms of Polybrominated Diphenyl Ethers.International journal of molecular sciences · 2023
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Minerva Mercado-FelicianoDepartment of Pharmacology and Toxicology, University School of Medicine, 975 W. Walnut St. (IB360), Indianapolis, IN 46202-5121 USA.
Robert M Bigsby
Indiana University – Purdue University Indianapolis · USIndiana University School of Medicine

Funding

Endocrine Regulation of Hepatocellular CarcinogenesisR21ES014367 · NIEHS · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI BIGSBY, ROBERT M · 2006 to 2007
$411k
Mechanisms of Xenoestrogen Action - Predoctoral MinorityF31ES013341 · NIEHS · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI MERCADO-FELICIANO, MINERVA · 2004 to 2006
$87k
NIEHS NIH HHS ES013341NIEHS NIH HHS ES014367NIEHS NIH HHS F31 ES013341NIEHS NIH HHS R21 ES014367
6 · The paper itself

Abstract

backgroundPolybrominated diphenyl ethers (PBDEs) are widely found in the environment, and they may act as endocrine disruptors.

objectiveOur goal in this study was to test the PBDE mixture DE-71 for estrogenic activity.

methodsWe used proliferation of cultured breast cancer cells (MCF-7) and trophic effects in the reproductive tracts of ovariectomized mice as estrogen bioassays. DE-71 was administered to mice by subcutaneous injection (sc) or oral gavage (po), alone or in combination with estradiol, for 3 or 34 days. Liver weights and cytochrome P450 enzyme activities were also measured.

resultsDE-71 increased MCF-7 cell proliferation, and this was prevented by antiestrogen. DE-71 cotreatment reduced the effect of estradiol in MCF-7 cells. In the mouse 3-day assay, DE-71 administered alone had no effect on uterine weight, uterine epithelial height (UEH), or vaginal epithelial thickness (VET); however, when DE-71 was administered as a cotreatment, it potentiated estradiol's effect on uterine weight. DE-71 administered sc to BALB/c mice for 34 days slightly increased UEH and VET, and attenuated the estradiol-induced increase in UEH; these effects were not seen in BALB/c mice treated po or in C57BL/6 mice treated sc. DE-71 increased liver weight in BALB/c, C57BL/6, and estrogen receptor-alpha knockout mice. We also found an increase in liver cytochrome P450 1A (CYP1A) and CYP2B activities when DE-71 was administered po, but only CYP2B increased after sc treatment.

conclusionDE-71 behaves as a weak estrogen. In mice, the treatment route and duration determined if DE-71 was estrogenic. BALB/c mice are more susceptible to DE-71 effects in estrogen target tissues than C57BL/6 mice. DE-71 increased liver weight independently of estrogen receptor-alpha.

Indexed as

AnimalsBiological AssayBreast NeoplasmsCell ProliferationCytochrome P-450 Enzyme SystemEndocrine DisruptorsEstradiolEstrogen Receptor ModulatorsFemaleHalogenated Diphenyl EthersLiverMiceMice, Inbred BALB CMice, Inbred C57BLOvariectomyPhenyl EthersCytochrome P-450 Enzyme SystemEndocrine DisruptorsEstradiolEstrogen Receptor ModulatorsHalogenated Diphenyl Etherspentabromodiphenyl etherPhenyl EthersPolybrominated BiphenylsCYP1ACYP2BDE-71endocrine disruptorsestrogensMCF-7miceovariectomizedPBDEspolybrominated diphenyl ethers

Identifiers

PMID18470304
PMCPMC2367668
OpenAlexW2019320153

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.